Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy President and CEO bought 250,000 shares at $1.67 ($418,450)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 70,000 shares at $1.40 ($98,000)
  12. 4 Open-market buy Principal Financial Officer bought 5,000 shares at $1.42 ($7,100)
  13. 4 Open-market buy Principal Financial Officer bought 2,500 shares at $5.30 ($13,250)
  14. 4 Open-market sale Chief Development Officer sold 22,073 shares at $5.15 ($113,713)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 12 · 221 filings